Cleared Traditional

K914823 - OMRON OSCILLOMETRIC DIGIT BLOOD PRES MO...

K914823 is the FDA 510(k) clearance for OMRON OSCILLOMETRIC DIGIT BLOOD PRES MO... by Omron Healthcare, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 425-day FDA review.

K914823 · Omron Healthcare, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1992
Decision
425d
Days
Class 2
Risk

K914823 is an FDA 510(k) clearance for the OMRON OSCILLOMETRIC DIGIT BLOOD PRES MONIT-HEM-706. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Omron Healthcare, Inc. (Vernon Hills, US). The FDA issued a Cleared decision on December 23, 1992 after a review of 425 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Omron Healthcare, Inc. devices

Submission Details

510(k) Number K914823 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 1991
Decision Date December 23, 1992
Days to Decision 425 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
300d slower than avg
Panel avg: 125d · This submission: 425d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 500
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K914823.
CRITIKON VITAL SIGNS MODULE
K915697 · Critikon Company, LLC · Jul 1993
OMRON OSCILLOMETRIC DIGITAL BLOOD PRESSURE MONIT.
K930798 · Omron Healthcare, Inc. · May 1993
OMRON WRIST DIGITAL BLOOD PRESSURE MONITOR HEM-601
K920778 · Omron Healthcare, Inc. · Dec 1992
NIBP 9225 COMBI
K912815 · S & W Medico Teknik · Oct 1992
BP PUMP
K921074 · Bio-Tek Instruments, Inc. · Oct 1992
NGM NIBP MODULE
K911645 · Datex Division Instrumentarium Corp. · Mar 1992